0001593968-24-000838.txt : 20240607 0001593968-24-000838.hdr.sgml : 20240607 20240607173046 ACCESSION NUMBER: 0001593968-24-000838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humer Franz B CENTRAL INDEX KEY: 0001548072 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 241030799 MAIL ADDRESS: STREET 1: 388 GREENWICH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2024-06-05 0001737287 Allogene Therapeutics, Inc. ALLO 0001548072 Humer Franz B 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false Common Stock 2024-06-05 4 A false 61475 0 A 316728 D Stock Option (Right to buy) 2.44 2024-06-05 4 A false 95541 0 A 2034-06-05 Common Stock 95541 95541 D Vesting in 12 equal monthly installments /s/Franz B. Humer 2024-06-07